NeuroServo
Montréal
About NeuroServo
NeuroServo has created VEEGix, a revolution in the medical EEG space. VEEGix is a miniaturised prefrontal EEG designed specifically to be used in emergency situation in Intensive Care Units. As opposed to traditionnal EEGs which require an EEG technician for the setup and a neurologist to interpret the data (causing a lead time of 4 hours in the best scenarios), VEEGix has been designed to be installed by nursed and to provide an interpretable status of the brain within a minute. VEEGix is not intended to replace a full traditionnal EEG but to be used as 1/ an emergency EEG when time matters (some pathologies have a treatment windows of less thant one hour before permanent brain damages), and 2/ as a cerebral monitoring device for patient under sedation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Funding stage: Seed
- Last round: Seed (Jun 2023)
- Website: neuroservo.com
- Phone: 514-536-0250
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/neuroservo-68189 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.